680 results on '"Macon, William R."'
Search Results
2. Announcements
3. Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL
4. Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements
5. Competing hematolymphoid classification schemes on deck
6. Cutaneous ALK-positive histiocytosis
7. Histiocyte-rich pseudotumor — a post-chemotherapy radiologic dilemma
8. Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study
9. Correction to: What, how, and when for the WHO: will the clock be turned back for the next hematolymphoid tumor classification?
10. Academic boycotts of Russian science: where does the Journal of Hematopathology stand?
11. Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era
12. Diagnostic Accuracy of a Defined Immunophenotypic and Molecular Genetic Approach for Peripheral T/NK-cell Lymphomas
13. Twenty years later: has cell of origin testing in diffuse large B cell lymphoma run its course?
14. What, how, and when for the WHO: will the clock be turned back for the next hematolymphoid tumor classification?
15. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping
16. A radiology survey and sub-sub-specialization in hematopathology
17. HISTOLOGIC FINDINGS IN VITREORETINAL LYMPHOMA: Learning From Enucleation Specimens
18. Hematolymphoid Lesions
19. Computational histopathology and deep transfer learning: characterizing the molecular basis of tumor morphology
20. Assessing for disease: recurrent mycosis fungoides or cutaneous granulomatous drug eruption after mogamulizumab therapy
21. Supplementary Data from Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494
22. SARS-CoV-2/COVID-19 pandemic produces a new paradigm for international hematopathology meetings
23. Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution
24. COVID-19 and remembering Professor Dennis H. Wright
25. Follicular Dendritic Cell Sarcoma With Indolent T-Lymphoblastic Proliferation is Associated With Paraneoplastic Autoimmune Multiorgan Syndrome
26. Peripheral T-Cell Lymphomas
27. Contributors
28. Mature T-Cell and Natural Killer–Cell Leukemias
29. Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma
30. BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma
31. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
32. Red tattoo‐related mycosis fungoides‐like CD8+ pseudolymphoma
33. Advancing diagnostic hematopathology: pigeons or pixels?
34. Keeping tabs on the mabs: a hematopathologist’s dilemma
35. Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study
36. CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies
37. Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era
38. Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: Results from two independent cohorts
39. The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender
40. Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: A clinic-based case-control study
41. Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma
42. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders
43. SOLAHP: a fledgling organization rapidly taking flight
44. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies
45. Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma
46. PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus
47. PET2 Response Associated with Survival in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Results of Two Independent Prospective Cohorts
48. Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria
49. Transition
50. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.